Ryewood Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 98.62%
- Profit Growth 10901.59%
- Ebitda 229.87%
- Net Worth 2.84%
- Total Assets 0.72%
About Ryewood Impex
Ryewood Impex Private Limited (RIPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 December 1999 and has a history of 25 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shobha Paharia and Ankit Paharia serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51900MH1999PTC123412
-
Company No.
123412
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Dec 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ryewood Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shobha Paharia
|
Director | 16-Aug-2021 | Current |
|
Ankit Paharia
|
Director | 16-Aug-2021 | Current |
Financial Performance of Ryewood Impex.
Ryewood Impex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.62% increase. The company also saw a substantial improvement in profitability, with a 10901.59% increase in profit. The company's net worth moved up by a moderate rise of 2.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ryewood Impex?
In 2023, Ryewood Impex had a public holding of 20.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Qualigens Pharma Private LimitedAnkit Paharia is a mutual person
-
Aawagaman Mercantile LlpShobha Paharia is a mutual person
-
Paharia Vintrade Llp
Shobha Paharia and Ankit Paharia are mutual person
-
Vichar Vimarsh Consultants Llp
Shobha Paharia is a mutual person
-
Vakunth Vinimay Llp
Shobha Paharia is a mutual person
-
Durlabh Consultancy Llp
Shobha Paharia and Ankit Paharia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ryewood Impex?
Unlock and access historical data on people associated with Ryewood Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ryewood Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ryewood Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
